Trial Profile
A randomized, double-blind, multicenter, dose-escalating study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of Piragliatin in patients with type-2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Piragliatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Roche
- 05 Nov 2010 New trial record.